· Investment Strategies · 3 sources · Updated · Verified

September 13–14 Investment News: Tandem $100M, Qupital $300M, Synapse $13M

Fresh Sep 13–14 tape: Tandem Health $100M Series B (EQT Scaleup’s first healthcare check), Qupital $300M Series C + ABS package, Synapse Analytics $13M Partech Series A — plus what we skipped (NeoCognition April reprint, Mecka talks).

By Venture Capital Tracker Editorial

Share
September 13–14 Investment News: Tandem $100M, Qupital $300M, Synapse $13M

September 13–14 printed three financings worth tracking after the Sep 10–12 Motive cluster: European clinic AI, Hong Kong e-commerce trade finance, and MENA bank-owned credit decisioning.

Deep dives

DateCompanyAmountStageLead / structureFollow-up
Sep 14Tandem Health$100MSeries BScaleup Europe Fund (EQT) — first healthcare check; $160M lifetimeTandem memo
Sep 13–14Qupital$300M combinedSeries C + ABSM Capital Series C anchor; MUFG + Quester ABS; split n/dQupital memo
Sep 14Synapse Analytics$13MSeries APartech; Algebra Ventures + Silicon Badia; $17M lifetimeSynapse Analytics memo

Why this set hangs together

  • Scaleup Europe Fund is still writing European category checks after Mistral and TEC — Tandem extends that book into MDR-grade clinic AI.
  • Qupital is a reminder that Asia fintech headlines often mix equity and structured credit; do not paste “$300M Series C” into a pure-equity table.
  • Synapse Analytics is a naming trap and a thesis: regulated lenders buy AI when data stays inside the perimeter.
ItemWhy
NeoCognition “$40M seed” reprints dated Sep 13Primary close was April 21, 2026 (TechCrunch / PR Newswire) — stale aggregator
Mecka AI ~$500M SequoiaTechCrunch talks, not closed
Pixxel $100M / Inspiren $70M / Boring / Positron / ClayAlready on main or open Sep 9–12 PRs

Day context

Prior index: September 10–12 Motive / Xapien / physical AI. Month hub: September 2026 VC News.

Follow Venture Capital Tracker on Google

Add VCT as a preferred source to see more of our venture-capital reporting in Google Search.

Add as preferred source

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Related articles

See all

Frequently Asked Questions

Direct answers to common questions about this topic

Back to Blog